{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:13:30Z","timestamp":1772802810421,"version":"3.50.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2565,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.bbmt.2008.02.006","type":"journal-article","created":{"date-parts":[[2008,3,14]],"date-time":"2008-03-14T10:05:35Z","timestamp":1205489135000},"page":"458-468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Transplantation in Remission Improves the Disease-Free Survival of Patients with Advanced Myelodysplastic Syndromes Treated with Myeloablative T Cell-Depleted Stem Cell Transplants from HLA-Identical Siblings"],"prefix":"10.1016","volume":"14","author":[{"given":"Hugo","family":"Castro-Malaspina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann A.","family":"Jabubowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esperanza B.","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farid","family":"Boulad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James W.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy A.","family":"Kernan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Perales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trudy N.","family":"Small","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharine","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Heller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy H.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh C.","family":"Jhanwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"van den Brink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen D.","family":"Nimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"O'Reilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2008.02.006_bib1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-100-5-689","article-title":"Allogeneic marrow transplantation in the treatment of preleukemia","volume":"100","author":"Appelbaum","year":"1984","journal-title":"Ann Intern Medic"},{"key":"10.1016\/j.bbmt.2008.02.006_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1182\/blood.V69.1.92.92","article-title":"Treatment of preleukemic syndromes with marrow transplantation","volume":"69","author":"Appelbaum","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood.V82.2.677.677","article-title":"Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome","volume":"82","author":"Anderson","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib4","first-page":"1997","article-title":"Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia","volume":"100","author":"Sierra","year":"2002","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.bbmt.2008.02.006_bib5","first-page":"S25","article-title":"Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcome analysis according to IPSS score","author":"Appelbaum","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2008.02.006_bib6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1182\/blood.V88.1.358.358","article-title":"Factors influencing outcome in de novo myelodysplastic syndromes treated by allogeneic bone marrow transplantation: a long term study of 71 patients","volume":"88","author":"Sutton","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/sj.bmt.1701084","article-title":"Bone marrow transplantation from HLA-identical siblings as first line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome","volume":"21","author":"Runde","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.02.006_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood.V87.1.51.51","article-title":"Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimen and analysis of prognostic factors","volume":"87","author":"Anderson","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1200\/JCO.1996.14.1.220","article-title":"Allogeneic marrow transplantation for myelodysplastic syndromes with advanced morphology: a phase II study of busulfan, cyclophosphamide and total body irradiation and analysis of prognostic factors","volume":"14","author":"Anderson","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.02.006_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1053\/bbmt.2002.v8.pm11939606","article-title":"Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and total body irradiation is associated with low relapse mortality but considerable non-relapse mortality","volume":"8","author":"Jurado","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.02.006_bib11","first-page":"745","article-title":"Treatment of patients with myelodysplastic syndromes with allogeneic bone marrow transplantation from genotypically HLA identical siblings and alternative donors","volume":"17","author":"Demuynck","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.02.006_bib12","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1046\/j.1365-2141.2000.02200.x","article-title":"Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukemias: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)","volume":"110","author":"de Witte","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2008.02.006_bib13","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1182\/blood.V98.8.2326","article-title":"Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDS) and acute leukemia following MDS","volume":"98","author":"de Witte","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib14","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2000.18.5.963","article-title":"Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute leukemia: a long-term study of 70 patients. Report of the French Society of Bone Marrow Transplantation","volume":"18","author":"Yakoub-Agha","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.02.006_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbmt.2004.10.001","article-title":"Pretransplantation induction chemotherapy and posttransplantation relapse in patients with advanced myelodysplastic syndrome","volume":"11","author":"Scott","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.02.006_bib16","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1182\/blood.V74.6.2227.2227","article-title":"Graft failure after T cell-depleted human leukocyte antigen identical marrow transplants for leukemia. I. Analysis of factors and results of secondary transplants","volume":"74","author":"Kernan","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib17","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood.V74.6.2237.2237","article-title":"Graft failure after T cell depleted human leukocyte antigen identical marrow transplants for leukemia. II. In vitro analysis of host effector mechanisms","volume":"74","author":"Bordignon","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib18","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1182\/blood.V86.4.1261.bloodjournal8641261","article-title":"Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-vs-leukemia from graft-vs-host disease","volume":"86","author":"Mackinnon","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib19","first-page":"1083","article-title":"T cell depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission","volume":"91","author":"Young","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib20","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood.V91.3.1083","article-title":"T cell depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease","volume":"91","author":"Papadopoulos","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib21","first-page":"131","article-title":"World Health Organization classification of acute leukemias and myelodysplastic syndromes","volume":"72","author":"Benneth","year":"2000","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2008.02.006_bib22","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib23","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2003.04.036","article-title":"Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcome, and reporting standards for therapeutic trials in acute myeloid leukemia","volume":"21","author":"Cheson","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.02.006_bib24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood-2005-10-4149","article-title":"Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia","volume":"108","author":"Cheson","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib25","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/0360-3016(83)90412-1","article-title":"Hyperfractionated total body irradiation for bone marrow transplantation. Results in seventy leukemia patients with allogeneic transplants","volume":"9","author":"Shank","year":"1983","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bbmt.2008.02.006_bib26","series-title":"Bone marrow and stem cell processing: a manual of current techniques","first-page":"171","article-title":"T cell depletion of bone marrow by treatment with soybean agglutinin and sheep red blood cell rossetting","author":"Collins","year":"1992"},{"key":"10.1016\/j.bbmt.2008.02.006_bib27","first-page":"223","article-title":"Comparison of bone marrow and G-CSF mobilized peripheral blood progenitors from single normal donors before and after T cell depletion","volume":"1","author":"Collins","year":"1999","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2008.02.006_bib28","first-page":"65","article-title":"Immune reconstitution following T cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis","volume":"3","author":"Small","year":"1997","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.02.006_bib29","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1365-2141.1997.1112925.x","article-title":"IBMTR severity index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade","volume":"97","author":"Rowlings","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2008.02.006_bib30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1053\/bbmt.2002.v8.pm12171485","article-title":"Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems","volume":"8","author":"MacMillan","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.02.006_bib31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","article-title":"Chronic graft-versus-host disease syndrome in man. A long-term clinicopathologic study of 20 Seattle patients","volume":"69","author":"Shulman","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.bbmt.2008.02.006_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non-parametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.bbmt.2008.02.006_bib33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.bbmt.2008.02.006_bib34","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.bbmt.2008.02.006_bib35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life table analysis (with discussions), Series B","volume":"34","author":"Cox","year":"1972","journal-title":"J Royal Stat Soc B"},{"key":"10.1016\/j.bbmt.2008.02.006_bib36","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of k-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"The Annals of Statistics"},{"key":"10.1016\/j.bbmt.2008.02.006_bib37","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/sj.bmt.1700739","article-title":"Outcome of allogeneic bone marrow transplantation with lymphocyte depleted marrow grafts in adult patients with myelodysplastic syndromes","volume":"19","author":"Mattijssen","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.02.006_bib38","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.blre.2006.03.002","article-title":"Autologous and allogeneic stem cell transplantation for myelodysplastic syndromes","volume":"21","author":"de Witte","year":"2006","journal-title":"Blood Reviews"},{"key":"10.1016\/j.bbmt.2008.02.006_bib39","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1182\/blood.V95.4.1188.004k38_1188_1194","article-title":"allogenic and syngeneic marrow transplantation for myelodysplastic syndromes in patients 55 to 66 years old","volume":"95","author":"Deeg","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib40","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1182\/blood.V99.12.4370","article-title":"Retrospective comparison of bone marrow and granulocyte colony stimulating factor mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes","volume":"99","author":"Guardiola","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib41","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1182\/blood-2004-02-0414","article-title":"Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS","volume":"104","author":"de Lima","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib42","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.bbmt.2005.05.004","article-title":"Improved outcome for peripheral blood stem cell transplantation for advanced primary myelodysplastic syndrome","volume":"11","author":"Solomon","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.02.006_bib43","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.bbmt.2006.06.003","article-title":"Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome","volume":"12","author":"Alyea","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.02.006_bib44","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.V94.1.333.413a31_333_339","article-title":"Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation","volume":"94","author":"Ruggeri","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib45","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1182\/blood-2004-12-4825","article-title":"Improved outcome in HLA-identical sibling hematopoietic stem cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes","volume":"105","author":"Hsu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib46","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1182\/blood.V99.6.1943","article-title":"Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis of 510 transplants facilitated by the National Marrow Donor Program","volume":"99","author":"Castro-Malaspina","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib47","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2002-02-0400","article-title":"Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes","volume":"100","author":"Martino","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib48","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood-2003-11-3750","article-title":"Non-ablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation","volume":"104","author":"de Lima","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib49","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/sj.leu.2404037","article-title":"Allogeneic hematopoietic stem transplantation in AML and MDS using myeloablative versus reduced intensity conditioning: the role of dose intensity","volume":"20","author":"Shimoni","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2008.02.006_bib50","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/sj.leu.2404010","article-title":"Myeloablative vs non-myeloablative allogeneic transplantation for patients with myelodysplastic syndrome and acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis","volume":"20","author":"Scott","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2008.02.006_bib51","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1182\/blood-2005-11-4503","article-title":"Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes","volume":"108","author":"Martino","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib52","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","article-title":"Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients","volume":"86","author":"Kolb","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib53","first-page":"975","article-title":"Adoptive immunotherapy with donor mononuclear cells infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation","volume":"18","author":"Porter","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.02.006_bib54","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","article-title":"Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation","volume":"15","author":"Collins","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.02.006_bib55","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.bmt.1704381","article-title":"Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome","volume":"33","author":"Depil","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.02.006_bib56","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1182\/blood.V84.9.3071.3071","article-title":"WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia","volume":"84","author":"Inoue","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib57","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1182\/blood.V90.3.1217","article-title":"High levels of Wilms' tumor gene (WT1) mRNA in acute myeloid leukemias are associated with a worse long term treatment","volume":"90","author":"Bergmann","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib58","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.leu.2401414","article-title":"WT1 and GATA1 expression in myelodysplastic syndrome and acute leukemia","author":"Patmasirivat","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2008.02.006_bib59","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1046\/j.1365-2141.2002.03728.x","article-title":"Abnormal WT1 expression in the CD-34 negative compartment in myelodysplastic bone marrow","volume":"118","author":"van Dyjk","year":"2002","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.bbmt.2008.02.006_bib60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002510050018","article-title":"Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms tumor gene (WT1) product","volume":"51","author":"Oka","year":"2000","journal-title":"Immunogenetics"},{"key":"10.1016\/j.bbmt.2008.02.006_bib61","doi-asserted-by":"crossref","first-page":"13885","DOI":"10.1073\/pnas.0405884101","article-title":"Induction of WT1 (Wilms tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resulting cancer regression","volume":"101","author":"Oka","year":"2004","journal-title":"Proc Nat Acad Sci"},{"key":"10.1016\/j.bbmt.2008.02.006_bib62","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1182\/blood-2007-06-093880","article-title":"Sustained engraftment and improved reconstitution: results of HLA-matched related, T cell depleted peripheral blood stem cell transplantation for adults with hematologic malignancies without the use of anti-thymocyte globulin","volume":"110","author":"Jakubowski","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib63","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1182\/blood.V88.5.1887.1887","article-title":"Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7","volume":"88","author":"Bolotin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib64","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood.V97.6.1525","article-title":"Interleukin 7 restores immunity in athymic T cell depleted hosts","volume":"97","author":"Fry","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib65","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1182\/blood.V97.5.1491","article-title":"IL-& increases both thymic-dependent and thymic-independent T cell regeneration after bone marrow transplantation","volume":"97","author":"Mackall","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib66","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1182\/blood.V98.7.2256","article-title":"Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease","volume":"98","author":"Alpdogan","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib67","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1172\/JCI200317865","article-title":"IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation","volume":"112","author":"Alpdogan","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2008.02.006_bib68","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1182\/blood.V99.12.4592","article-title":"Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T cell reconstitution after bone marrow transplantation","volume":"99","author":"Min","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib69","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1182\/blood.V100.2.682","article-title":"Keratonocyte growth factor preserves normal thymopoieis and thymic microenvironment during experimental graft-verus-host disease","volume":"100","author":"Rossi","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib70","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1182\/blood-2005-07-2831","article-title":"Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration","volume":"107","author":"Alpdogan","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib71","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s00277-003-0654-9","article-title":"Allogeneic stem cell transplantation after fludarabine\/busulfan based reduced intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia","volume":"82","author":"Kroger","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2008.02.006_bib72","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.bmt.1705259","article-title":"Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogenic stem cel transplantation in elderly patients with secondary acute leukemia or myelodysplastic syndrome","volume":"37","author":"Kroger","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2008.02.006_bib73","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1182\/blood-2003-12-4207","article-title":"Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulfan and alemtuzumab conditioning","volume":"104","author":"Ho","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2008.02.006_bib74","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1200\/JCO.2005.15.602","article-title":"Fludarabine, melphalan and alemtuzumab conditioning in adults with standard-risk advanced myeloid leukemia and myelodysplastic syndrome","volume":"23","author":"van Biesen","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2008.02.006_bib75","doi-asserted-by":"crossref","first-page":"9387","DOI":"10.1200\/JCO.2005.02.0057","article-title":"Allogeneic stem cell transplantation using a reduced intensity conditioning regimen that has the capacity to produce durable remission and long term disease free survival in patients with high risk acute myeloid leukemia and myelodysplasia","volume":"23","author":"Tauro","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879108000694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879108000694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:31:20Z","timestamp":1761057080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879108000694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S1083879108000694"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2008.02.006","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transplantation in Remission Improves the Disease-Free Survival of Patients with Advanced Myelodysplastic Syndromes Treated with Myeloablative T Cell-Depleted Stem Cell Transplants from HLA-Identical Siblings","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2008.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}